ILC Therapeutics
Newhouse
About ILC Therapeutics
ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.1M
- Last round: Series Unknown (Sep 2024)
- Website: ilctherapeutics.com
- Phone: +44 (0) 7403 554048
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/ilc-therapeutics-48297 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.